Digest Debate - DiabetesontheNet

Cardiovascular outcomes trials for glucose-lowering therapies: What do the results mean for practice?

What is the best first-line therapy for type 2 diabetes?

What can real-time continuous glucose monitoring data tell us?

Type 1 diabetes care: Are we doing enough?

What is the next treatment step in people with type 2 diabetes and poor glycaemic control despite optimised basal insulin?

Next generation in insulin pump technology: The bionic pancreas?

What are the practical complications people face when using insulin pumps?

What are people’s attitudes towards the safety and efficacy of bariatric surgery for the treatment of type 2 diabetes?

Nocturnal hypoglycaemia after exercise: Can it be avoided with closed-loop pump technology?

Internet-based interventions: A new modality for diabetes education?

Intensive lifestyle interventions: Is type 2 diabetes reversible?

Diabetes healthcare and mobile technology: Panacea or a false dawn?

Blood pressure: “The lower, the better”?

The ORIGIN study: Useful learning points despite null findings?

Exercise therapy in type 2 diabetes

Real-time continuous glucose monitoring in people with type 2 diabetes

Going too low: HbA1c targets for people at risk of cardiovascular disease

Under-reporting of diabetes in hospital admissions data